MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. Its discovery in 2015 by Dr. Changhan David Lee and colleagues at the University of Southern California represented a paradigm shift in mitochondrial biology, revealing that mitochondria can produce bioactive signaling peptides that regulate cellular metabolism. MOTS-c has since become an active subject of preclinical research investigating mitochondrial-nuclear communication and metabolic homeostasis.
Mitochondrial Genome Origin
Unlike the vast majority of known peptide hormones and signaling molecules, which are encoded by nuclear DNA, MOTS-c is encoded within the mitochondrial DNA (mtDNA). Specifically, it is derived from a short open reading frame within the 12S ribosomal RNA gene of the mitochondrial genome. This discovery was significant because mitochondria were previously thought to encode only 13 proteins, 22 transfer RNAs, and 2 ribosomal RNAs. The identification of MOTS-c and other mitochondrial-derived peptides (MDPs) such as humanin expanded the known coding capacity of the mitochondrial genome.
The mitochondrial origin of MOTS-c has important implications for its biology. Mitochondrial DNA is maternally inherited, has a higher mutation rate than nuclear DNA, and exists in multiple copies per cell. These characteristics mean that MOTS-c production may vary across individuals and cell types based on mtDNA copy number, heteroplasmy levels, and mitochondrial gene expression rates. Researchers studying mitochondrial genetics have found MOTS-c to be a valuable tool for investigating mtDNA-encoded peptide signaling.
AMPK Activation Research
One of the most well-characterized activities of MOTS-c in preclinical studies is its activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. In-vitro studies using multiple cell lines have demonstrated that MOTS-c treatment activates AMPK through mechanisms that involve alterations in the cellular folate cycle and de novo purine biosynthesis pathway. Specifically, MOTS-c has been shown to inhibit the folate cycle at the level of AICAR transformylase, leading to accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an endogenous AMPK activator.
This mechanism of AMPK activation is distinct from other known AMPK activators such as metformin or AICAR itself, making MOTS-c a unique research tool for studying AMPK-dependent metabolic pathways. In cell culture models, MOTS-c-induced AMPK activation has been associated with increased glucose uptake, enhanced fatty acid oxidation, and modulation of mitochondrial biogenesis markers.
Cellular Metabolism Research
Preclinical studies have investigated the effects of MOTS-c on multiple aspects of cellular metabolism. In-vitro experiments using skeletal muscle cell lines have demonstrated that MOTS-c treatment enhances glucose uptake through AMPK-dependent translocation of glucose transporter type 4 (GLUT4) to the cell membrane. These findings have been corroborated in animal model studies where MOTS-c administration in mice was associated with improved glucose tolerance and altered metabolic parameters.
Research into the effects of MOTS-c on lipid metabolism has revealed that AMPK activation by this peptide promotes fatty acid oxidation and inhibits lipogenic gene expression in cell culture models. Studies examining hepatocyte cell lines have reported decreased expression of sterol regulatory element-binding protein 1c (SREBP-1c) and fatty acid synthase (FAS) following MOTS-c treatment, consistent with AMPK-mediated suppression of de novo lipogenesis.
Mitochondrial-Nuclear Communication
MOTS-c has emerged as an important research tool for studying retrograde signaling from mitochondria to the nucleus. Under metabolic stress conditions, MOTS-c has been observed to translocate to the nucleus in cell culture models, where it interacts with nuclear transcription factors and modulates gene expression programs related to cellular stress response. This retrograde signaling function positions MOTS-c as a mediator of mitochondrial-nuclear crosstalk, a fundamental aspect of cellular adaptation to metabolic challenges.
Research using chromatin immunoprecipitation and gene expression profiling has identified MOTS-c-responsive gene networks involved in antioxidant defense, amino acid metabolism, and inflammatory regulation. These findings suggest that MOTS-c serves as a molecular messenger communicating mitochondrial metabolic status to the nuclear transcriptional machinery.
Age-Related Research
Preclinical studies have reported that circulating MOTS-c levels decline with age in both rodent models and human observational cohorts. This age-associated decline has generated research interest in the relationship between MOTS-c and metabolic changes observed during aging. In aged mouse models, MOTS-c administration was associated with improvements in physical performance metrics and metabolic parameters compared to vehicle-treated controls. These findings are strictly observational within preclinical contexts and require further mechanistic investigation.
Handling, Storage, and Research Use Notice
MOTS-c is supplied as a lyophilized powder and should be stored at negative twenty degrees Celsius. Reconstitution is typically performed with sterile water or bacteriostatic water, and the solution should be stored at two to eight degrees Celsius and used within two to three weeks. MOTS-c is sold exclusively for in-vitro and preclinical research use. It is not intended for human consumption or therapeutic application. All findings described in this article are derived from cell culture and animal model studies. Researchers must comply with all applicable regulatory and institutional guidelines.